MedsEngine Achieves SOC 2 Type II Certification: Reinforcing Our Commitment to Data Security
DAYTON, Ohio–(BUSINESS WIRE)–MedsEngine, a provider of chronic disease management software, is proud to announce that it has successfully attained SOC... Read more.
Red Arts Capital Promotes Drew Kelly to Vice President
Leading Investment Firm Continues to Expand Expertise and Empower Its People CHICAGO–(BUSINESS WIRE)–Red Arts Capital (“Red Arts”), a leading investment... Read more.
Pershing Square Holdings, Ltd. Launches Euro-Denominated Senior Notes Offering
LONDON–(BUSINESS WIRE)–Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced the launch of an offering of its euro-denominated... Read more.
InCred Alternatives Raises $70mn in Maiden Special Situations Fund, Aims for $175mn by Year End
MUMBAI, India–(BUSINESS WIRE)–#AlternativeInvestmentFund–InCred Alternative Investments Private Limited (“InCred Alternatives”), part of InCred... Read more.
TotalEnergies: Antwerp Platform Adapts to Energy Transition Challenges and Market Trends
ANTWERP, Belgium–(BUSINESS WIRE)–TotalEnergies’ (Paris:TTE) (LSE:TTE) (NYSE:TTE) Antwerp platform provides an update on its investments for the future... Read more.
Proofpoint Debuts Unified Data Security Protection Across Data Exfiltration, Exposure and Insider Threats
Agent-powered solution bridges the gap between data discovery, classification and real-time enforcement—eliminating manual bottlenecks and unlocking scalable data... Read more.
Proofpoint Unveils Industry’s First and Only Unified Solution to Reduce Costs and Cyber Risk Across the Expanding Workspace
Proofpoint Prime Threat Protection cuts complexity, extends protection across the full attack chain for all digital channels, lowers overhead spend, and brings agentic... Read more.
Geely Galaxy E5 Surpasses Global Safety Standards with Record 50km/h Crash Test
HANGZHOU, China–(BUSINESS WIRE)–On April 16, at the TECCON Laboratory in Austria, an institution accredited by Euro NCAP, the Geely Galaxy E5 successfully... Read more.
Egle Therapeutics to Highlight Novel Preclinical Findings for Regulatory T Cells Targeting Programs EGL-001 and EGL-002 With Poster Presentations at the 2025 AACR Annual Meeting
PARIS–(BUSINESS WIRE)–Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology... Read more.
Celonis Recognized as a Leader for Third Consecutive Year in 2025 Gartner® Magic Quadrant™ for Process Mining Platforms
NEW YORK & MUNICH–(BUSINESS WIRE)–Celonis, the global leader in Process Mining and Process Intelligence, today announced that it has been named a... Read more.